Study reveals early nicotinamide use reduces risk of aggressive skin cancers
Starting nicotinamide early after a first skin cancer could sharply cut future cancer risk, according to a real-world…
RAB26 identified as a critical regulator of prostate cancer aggressiveness
Prostate cancer (PCa) is one of the most common malignant tumors in men worldwide. While early detection has…